Dual Interaction is Present Between Epilepsy and Menopause

Summary

Hormonal fluctuations during perimenopause can worsen seizures in women with epilepsy and alter how their medications are processed, highlighting the need for personalized treatment strategies during this transition (Gillian et al., 2025).

FemTalkAsia Takeaways

• Increased Seizure Activity During Perimenopause: Studies indicate that approximately two-thirds of women with epilepsy experience a worsening of seizures as they transition into menopause, likely due to hormonal changes.
• Hormonal Impact on Medication Metabolism: Fluctuations in estrogen and progesterone levels can affect the body’s ability to process antiseizure medications, potentially leading to reduced drug effectiveness.
• Importance of Therapeutic Drug Monitoring: Healthcare providers may consider more frequent monitoring of antiseizure medication levels during perimenopause to ensure optimal seizure control.
• Role of Glucuronidation in Drug Clearance: Estrogen influences glucuronidation, a metabolic pathway that affects how quickly drugs are cleared from the body, which can impact medication levels and seizure control.
• Need for Individualized Treatment Approaches: Given the complex interaction between hormonal changes and epilepsy, personalized treatment plans are essential for managing seizure activity during menopause.